WPI 3385 (Bupropion Extended-Release (SR) 200 mg)
Pill imprint WPI 3385 has been identified as Bupropion hydrochloride extended-release (SR) 200 mg.
Bupropion is used in the treatment of depression; smoking cessation; anxiety; adhd; sexual dysfunction, ssri induced (and more), and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 3385 (Bupropion Extended-Release (SR) 200 mg)
- 200 mg
- Prescription only
- Drug Class:
- Miscellaneous antidepressants
Smoking cessation agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|21695-0020||Rebel Distributors Corp (repackager)|
|43063-0183||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
Bupropion hydrochloride extended-release (SR) is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...